Leukine is a Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Partner Therapeutics, Inc. The primary component is Sargramostim.
| Product ID | 71837-5843_178cab59-44ed-48f8-bd43-40da496962ff | 
| NDC | 71837-5843 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Leukine | 
| Generic Name | Sargramostim | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS | 
| Marketing Start Date | 1991-03-05 | 
| Marketing Category | BLA / BLA | 
| Application Number | BLA103362 | 
| Labeler Name | Partner Therapeutics, Inc | 
| Substance Name | SARGRAMOSTIM | 
| Active Ingredient Strength | 250 ug/mL | 
| Pharm Classes | Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2018-05-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA103362 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-05-07 | 
| Marketing Category | BLA | 
| Application Number | BLA103362 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2018-05-30 | 
| Ingredient | Strength | 
|---|---|
| SARGRAMOSTIM | 250 ug/mL | 
| SPL SET ID: | bb9a3820-f31a-4dd9-bef4-97094c01a398 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0024-5843 | Leukine | SARGRAMOSTIM | 
| 0024-5844 | Leukine | SARGRAMOSTIM | 
| 71837-5843 | Leukine | SARGRAMOSTIM | 
| 71837-5844 | Leukine | SARGRAMOSTIM | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() LEUKINE  73831918  1653426 Live/Registered  | 
        IMMUNEX CORPORATION  1989-10-13  |